 |
인쇄하기
취소
|
Kuhnil Signs Exclusive Marketing Rights for Senju’s Bronuck
Kuhnil Pharmaceutical recently acquired the exclusive domestic marketing rights for Bronuck (bromfenac sodium hydrate), an ophthalmic solution manufactured by Japan’s Senju Pharmaceuticals Co. Ltd.
Bronuck is a topical, twice daily, non-steroidal anti-inflammatory solution for the treatment of ocular inflammations. In the United States, ISTA Pharmaceuticals, Inc. has filed the New Drug Appl...
Bronuck is a topical, twice daily, non-steroidal anti-inflammatory solution for the treatment of ocular inflammations. In the United States, ISTA Pharmaceuticals, Inc. has filed the New Drug Appl...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.